BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11031227)

  • 21. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
    Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
    Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.
    Raal FJ; Pilcher G; Rubinsztein DC; Lingenhel A; Utermann G
    Atherosclerosis; 1997 Feb; 129(1):97-102. PubMed ID: 9069523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred.
    Haddad L; Day IN; Hunt S; Williams RR; Humphries SE; Hopkins PN
    J Lipid Res; 1999 Jun; 40(6):1113-22. PubMed ID: 10357843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of familial defective apolipoprotein B-100 among patients clinically diagnosed with heterozygous familial hypercholesterolemia in maritime Canada.
    Morash B; Guernsey DL; Tan MH; Dempsey G; Nassar BA
    Clin Biochem; 1994 Aug; 27(4):265-72. PubMed ID: 8001287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A genetic and clinical study in a family with familial hypercholesterolemia].
    Lai H; Feng JB; Wang T; Zhou KH; Hou WK; Chen L
    Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):120-3. PubMed ID: 21418831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.
    Gaffney D; Forster L; Caslake MJ; Bedford D; Stewart JP; Stewart G; Wieringa G; Dominiczak M; Miller JP; Packard CJ
    Atherosclerosis; 2002 May; 162(1):33-43. PubMed ID: 11947895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation screening of the LDLR gene and ApoB gene in patients with a phenotype of familial hypercholesterolemia and normal values in a functional LDL receptor/apolipoprotein B assay.
    Nissen H; Lestavel S; Hansen TS; Luc G; Bruckert E; Clavey V
    Clin Genet; 1998 Jul; 54(1):79-82. PubMed ID: 9727746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of six patients who are double heterozygotes for familial hypercholesterolemia and familial defective apo B-100.
    Rubinsztein DC; Raal FJ; Seftel HC; Pilcher G; Coetzee GA; van der Westhuyzen DR
    Arterioscler Thromb; 1993 Jul; 13(7):1076-81. PubMed ID: 8318509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypolipidemic effects of nicotinic acid in patients with familial defective apolipoprotein B-100.
    Schmidt EB; Illingworth DR; Bacon S; Russell SJ; Thatcher SR; Mahley RW; Weisgraber KH
    Metabolism; 1993 Feb; 42(2):137-9. PubMed ID: 8474308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial hypercholesterolemia in Morocco: first report of mutations in the LDL receptor gene.
    El Messal M; Aït Chihab K; Chater R; Vallvé JC; Bennis F; Hafidi A; Ribalta J; Varret M; Loutfi M; Rabès JP; Kettani A; Boileau C; Masana L; Adlouni A
    J Hum Genet; 2003; 48(4):199-203. PubMed ID: 12730724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation analysis in a small cohort of New Zealand patients originating from the United Kingdom demonstrates genetic heterogeneity in familial hypercholesterolemia.
    Thiart R; Varret M; Lintott CJ; Scott RS; Loubser O; du Plessis L; de Villiers JN; Boileau C; Kotze MJ
    Mol Cell Probes; 2000 Oct; 14(5):299-304. PubMed ID: 11040093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene.
    Al-Hinai AT; Al-Abri A; Al-Dhuhli H; Al-Waili K; Al-Sabti H; Al-Yaarubi S; Al-Hashmi K; Banerjee Y; Al-Zakwani I; Al-Rasadi K
    Angiology; 2013 May; 64(4):287-92. PubMed ID: 23162007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Identification of a novel splice mutation of low density lipoprotein receptor gene in a Chinese family with familial hypercholesterolemia].
    Lin J; Wang LY; Liu S; Pan XD; Du LP; Shi FR; Qin YW; Zhao Q; Guo HY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):14-8. PubMed ID: 14767901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial defective apolipoprotein B-100. Comparison with familial hypercholesterolemia in 18 cases detected in Munich.
    Schuster H; Rauh G; Kormann B; Hepp T; Humphries S; Keller C; Wolfram G; Zöllner N
    Arteriosclerosis; 1990; 10(4):577-81. PubMed ID: 2164382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
    Brugger D; Schuster H; Zöllner N
    Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the apo B-3500 mutation in the Norwegian population.
    Leren TP; Rødningen OK; Tonstad S; Røsby O; Urdal P; Ose L
    Scand J Clin Lab Invest; 1995 May; 55(3):217-21. PubMed ID: 7638555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [DNA analysis in heterozygotes in familial hypercholesterolemia].
    Horínek A; Slézka V; Sobra J; Ceska R
    Cas Lek Cesk; 1995 Apr; 134(8):234-9. PubMed ID: 7758080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compound heterozygous familial hypercholesterolemia in a Chinese boy with a de novo and transmitted low-density lipoprotein receptor mutation.
    Ma Y; Gong Y; Garg A; Zhou H
    J Clin Lipidol; 2018; 12(1):230-235.e6. PubMed ID: 29233637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
    Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
    Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.